Zimmerli M, Lerut J, Müller P, Zimmermann A, Nydegger U
Central Laboratory of Hematology, University Hospital, Bern, Switzerland.
Infusionstherapie. 1991 Apr;18(2):91-5. doi: 10.1159/000222701.
The concentrations of anti-A and anti-B IgM and IgG antibodies have been studied in the serum of a patient with blood group AB who received a type A donor liver. A newly developed ABO-ELISA was used for this purpose and the values were compared to hemagglutination titers. During the postoperative study period over 8 weeks, the anti-A and anti-B levels showed a higher fluctuation than was measured in preoperative samples. Thus, in this AB-type patient, anti-A IgM varied 10-fold, anti-A IgG 20-fold and anti-B IgG 16-fold. Peak values corresponded to rejection episodes. Immunoactivation in the patient was further documented by the presence of abnormally high levels of soluble interleukin-2 receptors (sIL-2R) in serum samples. The study shows that monitoring of anti-A/B antibodies may represent a further criterion to follow-up transplanted patients during the critical postoperative graft acceptance period.
对一名接受 A 型供体肝脏的 AB 血型患者血清中的抗 A 和抗 B IgM 及 IgG 抗体浓度进行了研究。为此使用了一种新开发的 ABO - ELISA,并将所得值与血凝滴度进行比较。在术后超过 8 周的研究期间,抗 A 和抗 B 水平的波动高于术前样本测量值。因此,在这名 AB 型患者中,抗 A IgM 变化了 10 倍,抗 A IgG 变化了 20 倍,抗 B IgG 变化了 16 倍。峰值与排斥反应发作相对应。血清样本中可溶性白细胞介素 - 2 受体(sIL - 2R)水平异常升高进一步证明了患者的免疫激活。该研究表明,监测抗 A/B 抗体可能是在术后关键的移植物接受期对移植患者进行随访的另一个标准。